EZH2 and neoplasm: Kunderfranco et al. performed a comprehensive analysis of the ETS gene family in prostatic normal and tumor tissues and established that the Polycomb group (PcG) protein EZH2 is a direct target of ERG and ESE3 and a key player in transcriptional silencing of the prostate-specific tumor suppressor gene Nkx3.1 [88].